Literature DB >> 23151358

The lipocalin-type prostaglandin D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early hypothalamic-pituitary-adrenal axis hyperactivity.

Jodi F Evans1, Shahidul Islam, Yoshihiro Urade, Naomi Eguchi, Louis Ragolia.   

Abstract

Obesity and diabetes are closely associated with hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis. In this study, the diet-induced obese C57BL/6 mouse was used to test the hypothesis that chronically elevated metabolic parameters associated with the development of obesity such as cholesterol and glucose can aggravate basal HPA axis activity. Because the lipocalin-type prostaglandin D(2) synthase (L-PGDS) knockout (KO) mouse is a model of accelerated insulin resistance, glucose intolerance, and obesity, it was further hypothesized that HPA activity would be greater in this model. Starting at 8 weeks of age, the L-PGDS KO and C57BL/6 mice were maintained on a low-fat or high-fat diet. After 20 or 37 weeks, fasting metabolic parameters and basal HPA axis hormones were measured and compared between genotypes. Correlation analyses were performed to identify associations between obesity-related chronic metabolic changes and changes in the basal activity of the HPA axis. Our results have identified strong positive correlations between total cholesterol, LDL-cholesterol, glucose, and HPA axis hormones that increase with age in the C57BL/6 mice. These data confirm that obesity-related elevations in cholesterol and glucose can heighten basal HPA activity. Additionally, the L-PGDS KO mice show early elevations in HPA activity with no age-related changes relative to the C57BL/6 mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23151358     DOI: 10.1530/JOE-12-0275

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  What Is the Role of the Adipocyte Mineralocorticoid Receptor in the Metabolic Syndrome?

Authors:  Celso E Gomez-Sanchez
Journal:  Hypertension       Date:  2015-05-11       Impact factor: 10.190

2.  Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.

Authors:  Sing Mei Lim; Dan Chen; Hsiangling Teo; Annette Roos; Anna Elisabet Jansson; Tomas Nyman; Lionel Trésaugues; Konstantin Pervushin; Pär Nordlund
Journal:  J Lipid Res       Date:  2013-03-22       Impact factor: 5.922

Review 3.  Regulation of inflammation by lipid mediators in oral diseases.

Authors:  S Sommakia; O J Baker
Journal:  Oral Dis       Date:  2016-08-04       Impact factor: 3.511

4.  Selective beneficial cardiometabolic effects of vertical sleeve gastrectomy are predominantly mediated through glucagon-like peptide (GLP-1) in Zucker diabetic fatty rats.

Authors:  Sunil Kumar; Raymond Lau; Thomas Palaia; Christopher Hall; Jenny Lee; Keneth Hall; Collin E Brathwaite; Louis Ragolia
Journal:  Ann Med Surg (Lond)       Date:  2016-11-17

5.  ER-depletion lowering the 'hypothalamus-uterus-kidney' axis functions by perturbing the renal ERβ/Ptgds signalling pathway.

Authors:  Yan-Ru Liu; Zhi-Shu Tang; Jin-Ao Duan; Lin Chen; Jing Sun; Rui Zhou; Zhong-Xing Song; Xin-Bo Shi; Hui-Yuan Zhu
Journal:  Aging (Albany NY)       Date:  2019-11-10       Impact factor: 5.682

6.  Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice.

Authors:  Wen-Liang Song; Emanuela Ricciotti; Xue Liang; Tilo Grosser; Gregory R Grant; Garret A FitzGerald
Journal:  J Pharmacol Exp Ther       Date:  2018-10-10       Impact factor: 4.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.